Overview of current therapies for rheumatoid arthritis

Journal of Rheumatology

Volumn 28, Issue SUPPL. 62, 2001, Pages 1-3

  Emery, P ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; METHOTREXATE; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT;

CONFERENCE PAPER; FUTUROLOGY; HUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; DIET THERAPY; REVIEW;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS;

EID: 0034981733     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Long-term treatment of rheumatoid arthritis with sulphasalazine, gold or penicillamine: A comparison using life-table methods
2. The effectiveness of early treatment with second-line antirheumatics: A randomized, controlled trial
3. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: A 3 year followup on the hydroxychloroquine in early arthritis (HERA) study
4. Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression
5. The acute phase in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome
6. Resistant rheumatoid arthritis clinics
7. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: A randomized trial
8. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications
9. Methotrexate (M)-hydroxychloroquine (H)-sulfasalazine (S) versus M-H or M-S for rheumatoid arthritis (RA): Results of a double-blind study